Carregant...
Treatment with the phosphodiesterase type 4 inhibitor rolipram fails to inhibit blood brain barrier disruption in MS
Rolipram, a prototypic phosphodiesterase-4 inhibitor is highly effective in suppressing Th1 autoimmunity in multiple animal models, including experimental autoimmune encephalomyelitis (EAE). Additionally, Rolipram has been extensively studied as a potential neuroprotective agent. Based on its anti-i...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3085182/ https://ncbi.nlm.nih.gov/pubmed/19776093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458509345903 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|